Stimcell Energetics (STME) Other financing activities (2019 - 2020)
Stimcell Energetics' (STME) quarterly Other financing activities came in at $124243.0 in Q3 2020, up 133.21% quarter-over-quarter from -$374148.0 in Q1 2020.
Stimcell Energetics (STME) Other financing activities (2019 - 2020) Analysis & Trends
Stimcell Energetics' Other financing activities history runs 2 years deep, the most recent figure standing at $124243.0 for Q3 2020.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $124243.0 in Q3 2020; TTM through May 2021 was $124243.0, a N/A change from a year earlier, with the FY2021 full-year figure at $124243.0, changed N/A from the prior year.
- Other financing activities grew to $124243.0 in Q3 2020 per STME's latest filing, from -$374148.0 in the prior quarter.
- Across five years, Other financing activities topped out at $374148.0 in Q4 2019 and bottomed at -$374148.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2020 | 124,243.00 |
| Aug 31, 2020 | 124,243.00 |
| Feb 29, 2020 | -374,148.00 |
| Feb 29, 2020 | -374,148.00 |
| Nov 30, 2019 | 374,148.00 |
| Nov 30, 2019 | 374,148.00 |